Suchergebnisse - "Woodfall, Brian"

PubPharm (30)

1

Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients : pooled 48 week analysis of two randomized, controlled trials

enthalten in: AIDS (London, England) | 2009

von Katlama, C. | Haubrich, R. | Lalezari, J. | +110

2

Effect of steady-state etravirine on the pharmacokinetics and pharmacodynamics of ethinylestradiol and norethindrone

enthalten in: Contraception | 2009

von Schöller-Gyüre, M. | Kakuda, T. | Woodfall, B. | +4

3

Effect of steady-state etravirine on the pharmacokinetics and pharmacodynamics of ethinylestradiol and norethindrone

enthalten in: Contraception | 2009

von Schöller-Gyüre, M. | Kakuda, T. | Woodfall, B. | +4

4

Efficacy and safety of etravirine (TMC125) in treatment-experienced HIV-1-infected patients : 48-week results of a phase IIb trial

enthalten in: AIDS (London, England) | 2009

von Cohen, C. | Berger, D. | Blick, G. | +9

5

Short-term randomized proof-of-principle trial of TMC278 in patients with HIV type-1 who have previously failed antiretroviral therapy

enthalten in: Antiviral therapy | 2009

von Arastéh, K. | Rieger, A. | Yeni, P. | +6

6

Efficacy and safety of etravirine (TMC125) in treatment-experienced HIV-1-infected patients: 48-week results of a phase IIb trial

enthalten in: Aids | 2009

von Cohen, C. | Berger, D. | Blick, G. | +9

7

Effect of steady-state etravirine on the pharmacokinetics and pharmacodynamics of ethinylestradiol and norethindrone

enthalten in: Contraception | 2009

von Schöller-Gyüre, M. | Kakuda, T. | Woodfall, B. | +4

8

A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV-negative volunteers

enthalten in: British journal of clinical pharmacology | 2008

von Schöller-Gyüre, M. | Kakuda, T. | De Smedt, G. | +5

9

Effects of different meal compositions and fasted state on the oral bioavailability of etravirine

enthalten in: Pharmacotherapy | 2008

von Schöller-Gyüre, M. | Boffito, M. | Pozniak, A. | +7

10

Safety, tolerability, and preliminary efficacy of 48 weeks of etravirine therapy in a phase IIb dose-ranging study involving treatment-experienced patients with HIV-1 infection

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2008

von Montaner, J. | Yeni, P. | Clumeck, N. | +9